AbbVie has decided against progressing a recommendation by the Pharmaceutical Benefits Advisory Committee for the listing of VENCLEXTA (venetoclax). …
Latest Video
New Stories
-
David Quilty retires from Pharmacy Guild
February 22, 2019 - - Latest News -
Takeda confirms Australian leadership
February 22, 2019 - - Latest News -
Fate of R&D tax reform a matter for election winner
February 22, 2019 - - Latest News -
Minister starts new round of listing announcements
February 22, 2019 - - Latest News -
Companies set to pass fundraising record in #PharmaCup2019
February 22, 2019 - - Latest News -
EBOS reports earnings growth as it prepares for Chemist Warehouse
February 21, 2019 - - Latest News -
MA: Where are the service standards and KPIs?
February 21, 2019 - - Latest News